Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells
暂无分享,去创建一个
George Stephanopoulos | Daehee Hwang | G. Stephanopoulos | D. Hwang | F. Dangond | A. Iglesias | Sandra I. Camelo | R. Villanueva | Antonio H Iglesias | Sandra Camelo | Raul Villanueva | Fernando Dangond
[1] T. Volkert,et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.
[2] S. Barnum,et al. Enhanced expression of chemotactic receptors in multiple sclerosis lesions , 1996, Journal of the Neurological Sciences.
[3] P. Brown,et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.
[4] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[5] G. Stephanopoulos,et al. A compendium of gene expression in normal human tissues. , 2001, Physiological genomics.
[6] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[7] C. Sardet,et al. Activation of E2F-mediated Transcription by Human T-cell Leukemia Virus Type I Tax Protein in a p16 INK4A -negative T-cell Line* , 1998, The Journal of Biological Chemistry.
[8] J. Bluestone,et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.
[9] R. Chignola,et al. Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum , 2003, Journal of Neuroimmunology.
[10] K. Ohtani,et al. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I , 2001, Oncogene.
[11] J. Golaz,et al. Activated T lymphocytes in patients with multiple sclerosis , 1983, Neurology.
[12] E. Shevach,et al. Cbl-b regulates the CD28 dependence of T-cell activation , 2000, Nature.
[13] Javed Khan,et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. , 2003, Human molecular genetics.
[14] M. Greenberg,et al. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. , 2001, Immunity.
[15] L. Ignarro,et al. Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice , 1998, The Journal of Immunology.
[16] James B. Johnston,et al. Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases , 2001, Annals of neurology.
[17] C. Koh,et al. Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[18] T. Kouzarides,et al. Regulation of E2F1 activity by acetylation , 2000, The EMBO journal.
[19] N. Dyson. The regulation of E2F by pRB-family proteins. , 1998, Genes & development.
[20] K. Ohtani,et al. Cell Type-specific E2F Activation and Cell Cycle Progression Induced by the Oncogene Product Tax of Human T-cell Leukemia Virus Type I* , 2000, The Journal of Biological Chemistry.
[21] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] David H. Miller,et al. A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.
[23] G. Karypis,et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] P. Hjelmström,et al. A Critical Role for Lymphotoxin in Experimental Allergic Encephalomyelitis , 1997, The Journal of experimental medicine.
[25] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[26] R. Slack,et al. The Transcription Factor E2F1 Modulates Apoptosis of Neurons , 2000, Journal of neurochemistry.
[27] J. DeGregori,et al. Defective Gene Expression, S Phase Progression, and Maturation during Hematopoiesis in E2F1/E2F2 Mutant Mice , 2003, Molecular and Cellular Biology.
[28] F. Barkhof,et al. Multiple sclerosis , 2003, Neurology.
[29] L. Staudt,et al. Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. , 2003, Brain : a journal of neurology.
[30] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[31] J. Nevins,et al. The E2F1–3 transcription factors are essential for cellular proliferation , 2001, Nature.
[32] M. Kotze,et al. Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. , 2001, Blood cells, molecules & diseases.
[33] C. McKerlie,et al. T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice1 , 2001, The Journal of Immunology.
[34] A. Cross,et al. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. , 1997, Journal of immunology.
[35] J. Haines,et al. Multiple susceptibility loci for multiple sclerosis. , 2002, Human molecular genetics.
[36] D Spiegelman,et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. , 2001, JAMA.
[37] Yihong Ma,et al. Identification of novel E2F1-regulated genes by microarray. , 2002, Archives of biochemistry and biophysics.
[38] B. Groner,et al. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. , 1997, Immunity.
[39] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[40] H. Andersen,et al. Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus? , 1992, Neuroepidemiology.
[41] J. Auwerx,et al. E2Fs regulate adipocyte differentiation. , 2002, Developmental cell.